Compare Medtronic PLC (MDT) vs Monster Beverage Corp (MNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Monster Beverage Corp — how do they compare? Medtronic PLC trades at $82.57 (market cap $106.61B), while Monster Beverage Corp trades at $94.87 (market cap $93.35B). The key difference: Medtronic PLC and Monster Beverage Corp are close in size by market cap, and Medtronic PLC pays a 3.46% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals.
| MDT | MNST | |
|---|---|---|
Market Cap | $106.61B | $93.35B |
Sector | Health | Consumer Staples |
52-Week High | $105.35 | $99.94 |
52-Week Low | $73.75 | $58.75 |
Enterprise Value | $125.36B | $91.65B |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Monster Beverage (MNST) trades at $95.79, down 1.75% over 24 hours but near its 52-week high of $99.53. The stock shows strong fundamentals with consistent earnings beats, revenue growth to $8.29B in 2025, and robust profitability margins. A 2-for-1 stock split announced for August 2026 reflects confidence, while technical indicators signal a bullish trend with support at $94.
Outlook remains positive driven by international expansion and product innovation, with a consensus price target of $97.83 offering modest upside. Risks include high valuation multiples and competitive pressures in the energy drink sector. Analyst sentiment is predominantly bullish, supporting a favorable investment case for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →
